University of Alabama, Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294-0017.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Alabama, Birmingham has participated in 76 clinical trials with 11 currently active.
Therapeutic areas: Alzheimer Disease, Type 2 Diabetes, Liver Dysfunction.
Sponsors: National Institute on Aging (NIA), University of Washington, Genzyme, a Sanofi Company.
Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Alabama, Birmingham has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama, Birmingham has 76 clinical trials on record, with 11 currently active. Their work covers Alzheimer Disease, Type 2 Diabetes, Liver Dysfunction.
Yes — University of Alabama, Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.